All Blogs

Sep 15, 2020

AstraZeneca/ Oxford resumes the trial of their COVID-19 vaccine in the UK After receiving a go-ahead from the UK’s Medicines Health Regulatory Authority, AstraZeneca and the University of Oxford have resumed the trials of their experimental coronavirus candidate AZD1222 in the country. A rapid review by the tria...

Nov 08, 2024

Cervical cancer stands as the fourth most diagnosed cancer among women globally, trailing breast, colorectal, and lung cancers. However, its impact is disproportionately heavy on developing nations, where prevalence rates soar. In 2022, WHO estimated approximately 660,000 new cases of cervical cancer and 350,000 de...

Sep 11, 2020

In the span of a decade, the Acromegaly pipeline therapies, including IONIS-GHR-LRx (Ionis Pharmaceuticals), ATL1103 (Antisense Therapeutics), CAM2029 (Camurus), Veldoreotide (Strongbridge Biopharma), CRN00808 (Crinetics Pharmaceuticals), and Lanreotide PRF (Ipsen) are set to launch. What happens when the grow...

Sep 10, 2020

Pfizer, BioNTech report shows the immune response in animals to COVID-19  Pfizer and its partner BioNTech have five potential COVID-19 vaccines in clinical trials, each based on a different mRNA format. The companies are now exhibiting that the most advanced candidate, BNT162b2, performed well in trials in ...

Sep 09, 2020

Alternative Medicine often referred to as “integrative,” or  “complementary” medicine,  including a wide range of medical treatments, products, practices, and health care systems that are not a part of standard/ conventional medical care. Alternative medicine is categorized together with complementary med...

Sep 08, 2020

Cycle Pharmaceuticals Hauls In USD 25 Million In A Debt Financing Agreement  Cycle Pharmaceuticals, a biotech company focusing exclusively on rare diseases, announced a strategic financing agreement worth USD25 million credit facility with Deutsche Bank AG.  Headquartered in the UK, Cycle Pharmaceut...

Jul 19, 2024

A cancer of plasma cells, a malignant plasma cell dyscrasia, Multiple Myeloma is a cancer that accumulates in the bone marrow leading to the number of healthy blood cells to plunge. The condition results in osteolysis due to an increase in osteoclastic and decreased osteoblastic activity. Multiple myeloma predom...

Sep 03, 2020

Amylyx's neuron-protecting drug slows ALS decline in the late-phase study A novel combination of compounds has displayed that it can help decrease amyotrophic lateral sclerosis (ALS) by supporting the brain's neurons' inner workings. After six months of treatment, AMX0035 of Amylyx Pharmaceuticals demonstrate...

Sep 04, 2020

The Keratoconus market will be dominated by lenses, cross-linking procedures as well as IVMED-80, if approved in the coming decade. Keratoconus, away from the general perception of a rare disease, has come a long way. Thirty-four years back, in Minnesota, United States, this disease was claimed as rare, which ...

Sep 02, 2020

The healthcare industry over the past decade has observed revolutionary changes. Technology along with human expertise has completely changed the process of prevention, diagnosis, and treatment of diseases at almost every level of the healthcare delivery system.  The health system or healthcare delivery sys...